Unibest
← Back to patent-cliff list

CAS 330792-68-2

2-(hydroxy(4-phenoxyphenyl)methylene)malononitrile(4-Phenoxybenzoyl)malononitrile

Codes: IBRT-002, (III)461018-3-a, (V)461018-4-a, ZANU-003

Application context (from source-drug indications)

Waldenström macroglobulinaemiaIbrutinibChronic lymphocytic leukaemiaIbrutinibMantle cell lymphomaIbrutinibGraft-versus-host diseaseIbrutinibWaldenström macroglobulinaemiaZanubrutinibChronic lymphocytic leukaemiaZanubrutinibFollicular lymphomaZanubrutinibMarginal zone B-cell lymphomaZanubrutinibMantle cell lymphomaZanubrutinib

Source drugs (routes using this intermediate)

DrugTierExpiry
IbrutinibTier A — Act now2027
ZanubrutinibTier A — Act now2031

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.